AKT1 and breast carcinoma: Aberrant PI3K/AKT signaling regulates H3K4 methylation through the activity of H3K4-directed enzymes in HR+ breast cancer (6, 7) and high H3K4 methylation is associated with poor prognosis in breast and other cancers (8).